药品抽检在健康中国建设中发挥的作用探讨  

Discussion on the Role of Drug Sampling and Testing in the Construction of Healthy China

作　　者：朱炯[1] 刘文[1] 王翀[1] 胡增峣 ZHU Jiong;LIU Wen;WANG Chong;HU Zengyao(National Institutes for Food and Drug Control,Beijing 102629,China;National Medical Products Administration,Beijing 100037,China)

机构地区：[1]中国食品药品检定研究院,北京102629 [2]国家药品监督管理局,北京100037

出　　处：《中国现代应用药学》2021年第24期3182-3187,共6页Chinese Journal of Modern Applied Pharmacy

摘　　要：目的通过探讨中国药品抽检对健康中国的作用,为加强药品抽检促进健康中国建设提供参考。方法分析健康中国建设对药品质量的要求以及药品抽检对药品质量提升和健康中国建设的作用,为药品抽检更好助力健康中国建设提出建议。结果健康中国建设需要优质的药品,然而药品质量风险具有客观性,药品监管需常抓不懈。中国药品抽检覆盖药品生产、经营和使用环节以及高风险品种,以问题为导向防控药品质量风险并严惩不法行为,使中国药品总体质量处于较高水平,并且可以通过减少假劣药品、提升药品质量和警示用药风险为健康中国建设贡献力量。结论中国药品抽检对健康中国建设具有重要意义,下一步工作中应践行“四个最严”要求、提高抽检品种遴选的靶向性、联合惩戒制售假劣药品行为、加大查处力度,更好地为健康中国建设把好药品质量关。OBJECTIVE To provide references for strengthening drug sampling and testing to promote the construction of“Healthy China”by discussing the role of drug sampling and testing in China in the construction of“Healthy China”.METHODS Analyzed the requirements of the construction of“Healthy China”on drug quality and the effect of drug sampling and testing on the improvement of drug quality and the construction of“Healthy China”,and put forward suggestions for drug sampling and testing to better contribute to the construction of“Healthy China”.RESULTS The construction of“Healthy China”required high-quality drugs,but drug quality risks were objective,and drug supervision needed to be constantly focused.Drug sampling and testing in China covered the production,circulation,and use of drugs and high-risk varieties.It was problem-oriented to prevent and control drug quality risks and severely punish illegal behaviors,so that the overall quality of Chinese drugs was at a high level,and it could be contribute to the construction of“Healthy China”by reducing counterfeit and inferior drugs,improving the quality of drugs and warning of drug risks.CONCLUSION The drug sampling and testing in China has great significance to the construction of“Healthy China”.In the next step,the“four strictest”requirements should be implemented,the selection targeting of sampling and testing varieties should be improved,and the production and sale behaviors of counterfeit and inferior drugs should be jointly punished and the punishment should be strengthened,so as to better control the quality of drugs for the construction of“Healthy China”.

关 键 词：药品抽检 健康中国 质量风险 假劣药品 联合惩戒 

分 类 号：R951[医药卫生—药学]